[1] |
CAO Hong-tao, WANG Xiao-long, CHEN Liang, LIN Bo, TANG Ting-ting, MA Ke-qiang, JI Teng-fei, CAO Tian-sheng, WANG Jian, ZHANG Wen-wei, YANG Jian-rong, LU Zhuo-cai, YOU Tian, HE Qing-qing, HUANG Jin-min, ZHOU Ti-xia.
Experience in the treatment of SOX neoadjuvant chemotherapy in advanced gastric cancer
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(06): 631-635.
|
[2] |
ZHONG Cui-yu, WANG Jia-wei, HUANG Kang-ling, YAO Yan-dan.
Predictive value of lymphocyte subsets for efficacy of neoadjuvant chemotherapy in breast cancer
[J]. Lingnan Modern Clinics In Surgery, 2021, 21(01): 74-81.
|
[3] |
WANG Yongnan1, YAN Shanshan2.
Progress in the application of circulating tumor cells in neoadjuvant chemotherapy for breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2019, 19(06): 763-766.
|
[4] |
WANG Yongnan,LI Wenping,YU Haiyun,WAN Jian.
Effect of postoperative adjuvant chemotherapy on prognosis of elderly breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2017, 17(02): 198-201.
|
[5] |
RAO Xinhui,LIANG Jinsong,ZHANG Zizheng,CHEN Gang.
Application of gastric tube in combined thoracoscopic-laparoscopic esophagectomy for treatment of esophageal carcinoma
[J]. Lingnan Modern Clinics in Surgery, 2017, 17(01): 72-76.
|
[6] |
LIU Yuan, GUI Yifei, LIAO Wenyong, HUANG Yanping, LIU Lingli.
Analysis of sentinel lymph node biopsy by blue dye trace method for breast cancer patients after neoadjuvant chemotherapy
[J]. Lingnan Modern Clinics in Surgery, 2016, 16(05): 569-573.
|
[7] |
ZHANG Mengdi, CHEN Jianyu, GONG Shu, LI Yong, ZHENG Guifen.
The progress of current magnetic resonance imaging methods for predicting the response of breast cancer to neoadjuvant chemotherapy
[J]. Lingnan Modern Clinics in Surgery, 2016, 16(05): 511-516.
|
[8] |
ZHUANG Yezhong, LIN Jiarui, HUANG Miansheng, WANG Weifeng, XU Muming.
Neoadjuvant chemotherapy for resectable locally advanced colon carcinoma:a prospective case controlled trial
[J]. Lingnan Modern Clinics in Surgery, 2016, 16(03): 266-269.
|
[9] |
LUO Wei, CHEN Yi, LIANG Gehao, GONG Chang.
Levels of TOPOⅡ and P53 predict the efficacy of neoadjuvant chemotherapy in breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2016, 16(02): 127-131.
|
[10] |
Chen Yi, Guan Xiaofeng, Nie Yan, Gong Chang, Song Erwei.
C-reactive protein predicts pathologic complete response to neoadjuvantchemotherapy in breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2015, 15(02): 125-131.
|
[11] |
Lv Zejian, Zhang Yuchao, Liu Yeqing, Liu Gaojie, Chen Shuang.
One case report of pathological complete remission of rectal cancer after neoadjuvant chemotherapy and review of literature
[J]. Lingnan Modern Clinics in Surgery, 2014, 14(01): 73-75.
|
[12] |
Wang Yongnan, Wang Qi, Zhang Anqin, Li Wenping, Han Xiaorong, Cheng Zhongyang.
Clinical value of the changes of ER,.PR,.HER2 and Ki?鄄67 expressions before and after neoadjuvant chemotherapy in breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2013, 13(04): 308-312.
|
[13] |
.
Response and prognosis of TAC neoadjuvant chemotherapy in patients with triple negative breast cancer
[J]. Lingnan Modern Clinics in Surgery, 2012, 12(03): 187-189.
|